These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8677453)

  • 21. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and toxicity of combination chemotherapy with ifosfamide, vinorelbine, cisplatin versus ifosfamide, vinorelbine in patients with advanced non small cell lung cancer.
    Mencoboni M; Lerza R; Castello G; Arboscello E; Barsotti BP; Cerruti A; Ballarino P; Botta M; Bogliolo G; Pannacciulli I
    Anticancer Res; 1997; 17(4A):2795-8. PubMed ID: 9252717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.
    Perez EA; Gandara DR
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):2-5. PubMed ID: 8209273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.
    Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B
    Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ifosfamide and docetaxel in non-small cell lung cancer.
    Drings P; Büchholz E; Manegold C
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):29-37. PubMed ID: 9535209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
    Demetri GD
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide and mesna in epithelial ovarian carcinoma.
    Sutton G
    Gynecol Oncol; 1993 Oct; 51(1):104-8. PubMed ID: 8244163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of ifosfamide in small cell and non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):24-30. PubMed ID: 2159187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial".
    Holoye PY
    Cancer Treat Rep; 1987 Apr; 71(4):431-2. PubMed ID: 3030548
    [No Abstract]   [Full Text] [Related]  

  • 35. Ifosfamide in the treatment of bladder cancer.
    Roth BJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):50-5. PubMed ID: 8677450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
    Ingle JN; Krook JE; Mailliard JA; Hartmann LC; Wieand HS
    Am J Clin Oncol; 1995 Dec; 18(6):498-501. PubMed ID: 8526193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
    Pronzato P; Vigani A; Pensa F; Vanoli M; Tani F; Vaira F
    Am J Clin Oncol; 1997 Oct; 20(5):519-21. PubMed ID: 9345341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epileptic seizures and treatment with ifosfamide-mesna].
    Somma-Mauvais H; Farisse P; Viallat JR
    Rev Neurol (Paris); 1994; 150(4):307-8. PubMed ID: 7863185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Dorr RT
    Semin Oncol; 1990 Aug; 17(4 Suppl 7):2-5. PubMed ID: 2116668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.